Neonatal Pain
5
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
ShotBlocker During Intramuscular Injection Randomized Control Trial
Effect of Two Non-pharmacological Method on Pain, Stress Procedure Duration in Newborn
Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants
Effectiveness of the Z-Track Technique As a Pain-Reducing Strategy for Neonates During Intramuscular Injection: a Randomized Controlled Trial
Efficacy of 50% Oral Dextrose As Pain Relief in Newborns Before Bladder Catheterization